BRUKINSA for MCL Approved in Russia
Source: https://unsplash.com/photos/ZHys6xN7sUE

BRUKINSA for MCL Approved in Russia

BRUKINSA (zanubrutinib), an orally administered Bruton's tyrosine kinase (BTK) inhibitor, has been approved in various countries for the treatment of mantle cell lymphoma (MCL), Waldenström's macroglobulinemia, and marginal zone lymphoma. For…

Continue Reading BRUKINSA for MCL Approved in Russia
Compassion Corner: When Families are Involved with the Care of Their Critically-Ill Loved Ones
source: pixabay.com

Compassion Corner: When Families are Involved with the Care of Their Critically-Ill Loved Ones

Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

Continue Reading Compassion Corner: When Families are Involved with the Care of Their Critically-Ill Loved Ones